PvP Biologics

PvP Biologics

PvP Biologics

Our mission is to develop a highly-effective therapeutic that reduces the burden of living with #celiac disease.
Type
B2b
Founded
2016
Raised
$35M
Follow us
Alexa global traffic share
Twitter followers
Acquired by
Takeda
26 Feb 2020
Latest funding
$35,000,000
Venture capital - 2017
Takeda Pharmaceutical
GeekWire

After buying Seattle startup PvP Biologics for $330M, Takeda to advance celiac disease treatment

$35,000,000 Venture capital
Xconomy , socalTECH.com

PvP Biologics Raises $35M in a Lab-to-Pharma Deal with Takeda

Robotics Science Health